Sinocelltech Group Ltd Market Cap ($2.08 Billion)
Market Cap & Net Worth: Sinocelltech Group Ltd (688520)
Sinocelltech Group Ltd market cap. Sinocelltech Group Ltd (SHG:688520) has a market capitalization of $2.08 Billion (CN¥14.21 Billion) as of November 8, 2026. Listed on the SHG stock exchange, this China-based company holds position #5821 globally and #1061 in its home market, demonstrating a 0.85% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sinocelltech Group Ltd's stock price CN¥31.90 by its total outstanding shares 445335714 (445.34 Million). Also see 688520 operating cash flow for how efficiently the company converts equity into cash flow.
Sinocelltech Group Ltd Market Cap History (2020–2026)
Sinocelltech Group Ltd market cap history from 2020 to 2026. Data shows change from $2.97 Billion to $2.08 Billion (-12.19% CAGR). Check Sinocelltech Group Ltd share price for real-time trading data and today's change.
Sinocelltech Group Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sinocelltech Group Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Sinocelltech Group Ltd (688520) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.94x
Sinocelltech Group Ltd's market cap is 0.94 times its annual revenue
Latest Price to Earnings (P/E) Ratio
21.09x
Sinocelltech Group Ltd's market cap is 21.09 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $2.97 Billion | $328.17K | -$712.50 Million | 9045.27x | N/A |
| 2021 | $3.81 Billion | $134.39 Million | -$866.85 Million | 28.34x | N/A |
| 2022 | $3.95 Billion | $1.02 Billion | -$519.00 Million | 3.86x | N/A |
| 2023 | $3.51 Billion | $1.89 Billion | -$396.02 Million | 1.86x | N/A |
| 2024 | $2.36 Billion | $2.51 Billion | $111.95 Million | 0.94x | 21.09x |
Competitor Companies of 688520 by Market Capitalization
Companies near Sinocelltech Group Ltd in the global market cap rankings as of November 8, 2026. Also see how large is Sinocelltech Group Ltd's balance sheet for a full breakdown of the balance sheet.
Key companies related to Sinocelltech Group Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #177 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #363 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #403 globally with a market cap of $69.36 Billion USD ( AU$98.02 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #177 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $547.09 |
| #363 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $904.35 |
| #403 | CSL Ltd | AU:CSL | $69.36 Billion | AU$202.04 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $254.19 |
Market Capitalization of Sinocelltech Group Ltd (2020–2026)
Market capitalization of Sinocelltech Group Ltd from 2020 to today. Between 2020 and today, Sinocelltech Group Ltd's market cap moved from $2.97 Billion to $ 2.08 Billion, with a yearly change of -12.19%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥2.08 Billion | -26.34% |
| 2025 | CN¥2.82 Billion | +19.54% |
| 2024 | CN¥2.36 Billion | -32.75% |
| 2023 | CN¥3.51 Billion | -11.11% |
| 2022 | CN¥3.95 Billion | +3.68% |
| 2021 | CN¥3.81 Billion | +28.32% |
| 2020 | CN¥2.97 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Sinocelltech Group Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.08 Billion USD |
| MoneyControl | $2.08 Billion USD |
| MarketWatch | $2.08 Billion USD |
| marketcap.company | $2.08 Billion USD |
| Reuters | $2.08 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sinocelltech Group Ltd
Sinocelltech Group Limited, a biopharmaceutical company, engages in the research, development, and production of recombinant proteins, antibody drugs, and vaccines in China. The company offers Anjiayin, a third-generation recombinant coagulation factor VIII product for the treatment of hemophilia A; Anpingxi, an anti-CD20 monoclonal antibody for the treatment of CD20-positive diffuse large B-cell… Read more